Triamterene And Hydrochlorothiazide
Product Images NDC 61919-338

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 61919-338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Directrx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

304 (61919 0304 90)

304 (61919 0304 90)
This text seems to be a label of a medication named Triamterene/HCTZ, which comes in the form of tablets. The medicine contains Triamterene, USP (37.5mg) and Hydrochlorothiazide (25mg). It is available in packages of 90 tablets (NDC 51919304-90). The medication is also known as MAXZIDE and comes with the Lot 1802104 Exp 191723. Additionally, the label has information about the manufacturer, dosage, and a bar code.*
FDA Label Image

Label (Triamhydro338)

Label (Triamhydro338)
Description: This is a medication with Hydrochlorothiazide, USP 25mg and Triamterene, USP 37.5mg. Each tablet contains these two ingredients and is called MAXZIDE H, which comes in a bottle of 30 tablets. There is also information about the lot number and the expiration date of the medication on the bottle.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.